[Federal Register: June 17, 2004 (Volume 69, Number 116)]
[Notices]
[Page 33904-33905]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17jn04-55]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-04-66]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 498-1210.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Send comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-E11,
Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Written comments
should be received within 60 days of this notice.
Proposed Project
Validating Autism Surveillance Methodology in Metropolitan Atlanta
Developmental Disabilities Surveillance Program (MADDSP)--New--National
Center on Birth Defects and Developmental Disabilities (NCBDDD),
Centers for Disease Control and Prevention (CDC).
Background
MADDSP was established in 1991 as an ongoing active surveillance
system for select developmental disabilities (mental retardation,
cerebral palsy, vision impairment, and hearing loss) in 3 to 10 year
old children. In 1996, autism spectrum disorders (ASD) was added to
MADDSP due to growing concern about the prevalence of the condition.
MADDSP defines ASD as a constellation of social, communicative,
[[Page 33905]]
and behavioral impairments consistent with the DSM-IV-TR diagnostic
criteria for Autistic Disorder, Asperger's Disorder, and Pervasive
Developmental Disorders not otherwise specified.
MADDSP relies on an extensive review of records to identify
children with an ASD. Potential case records are identified from
multiple sources which are likely to maintain evaluation or treatment
records for children with ASD. Pertinent ICD-9, DSM-IV codes and
predetermined behavioral descriptions are used to trigger records for
abstraction. Clinical experts then review the abstracted data and
determine case status based on a behavioral coding scheme that is in
accordance with the DSM-IV-TR definition for Pervasive Developmental
Disorders.
This record review methodology for ASD surveillance has been
executed and is being used; however, the method is not currently
validated by a clinical sample which is considered the gold standard
for identifying ASD. For this reason, it is important to validate
surveillance methods in a clinical sample in order to determine whether
current surveillance methodology accurately captures prevalence
estimates for this developmental outcome. The sensitivity and
specificity of MADDSP will be measured using judgments from the
clinical exam as the gold standard. The results from this study will
provide important implications for how ASD surveillance is maintained.
Primary caregivers of children already identified through
surveillance methods will be contacted, informed of the study, and
asked to participate through an invitation letter and/or telephone
contact. Clinic visits will be scheduled for all children whose primary
caregiver agrees to take part in the study and who signs a written
informed consent; child assent will be obtained at the time of the
clinic visit. Data collection methods will consist of: (1) Parental
questionnaires, which will focus on questions about their child's
behavior and developmental history; and, (2) a developmental evaluation
for the child participant, which includes a play based assessment
specific to ASD and a measure of cognitive development. There is no
cost to respondents.
Annualized Burden Table:
----------------------------------------------------------------------------------------------------------------
No. of Avg. burden per
Survey instruments No. of responses per response (in Total burden
respondents respondent hours) hours
----------------------------------------------------------------------------------------------------------------
Parental questionnaires..................... 250 1 3 750
Child developmental evaluation measures..... 250 1 2 500
------------------
Total................................... ............... ............... ............... 1250
----------------------------------------------------------------------------------------------------------------
Dated: June 10, 2004.
Alvin Hall,
Director, Management Analysis and Services Office Centers for Disease
Control and Prevention.
[FR Doc. 04-13710 Filed 6-16-04; 8:45 am]
BILLING CODE 4163-18-P